Literature DB >> 22431061

Transcriptomic analysis of the woodchuck model of chronic hepatitis B.

Simon P Fletcher1, Daniel J Chin, Yongmei Ji, A Leonardo Iniguez, Bruce Taillon, David C Swinney, Palanikumar Ravindran, Donavan T Cheng, Hans Bitter, Uri Lopatin, Han Ma, Klaus Klumpp, Stephan Menne.   

Abstract

UNLABELLED: The Eastern woodchuck (Marmota monax) is naturally infected with woodchuck hepatitis virus (WHV), a hepadnavirus closely related to the human hepatitis B virus (HBV). The woodchuck is used as an animal model for studying chronic hepatitis B (CHB) and HBV-associated hepatocellular carcinoma (HCC) in humans, but the lack of sequence information has hitherto precluded functional genomics analysis. To address this major limitation of the model, we report here the sequencing, assembly, and annotation of the woodchuck transcriptome, together with the generation of custom woodchuck microarrays. Using this new platform, we characterized the transcriptional response to persistent WHV infection and WHV-induced HCC. This revealed that chronic WHV infection, like HBV, is associated with (1) a limited intrahepatic type I interferon response; (2) intrahepatic induction of markers associated with T cell exhaustion; (3) elevated levels of suppressor of cytokine signaling 3 (SOCS3) in the liver; and (4) intrahepatic accumulation of neutrophils. Underscoring the translational value of the woodchuck model, this study also determined that WHV-induced HCC shares molecular characteristics with a subtype of human HCC with poor prognosis.
CONCLUSION: Our data establish the translational value of the woodchuck model and provide new insight into immune pathways which may play a role either in the persistence of HBV infection or the sequelae of CHB.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22431061      PMCID: PMC3401284          DOI: 10.1002/hep.25730

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

Authors:  Derek Y Chiang; Augusto Villanueva; Yujin Hoshida; Judit Peix; Philippa Newell; Beatriz Minguez; Amanda C LeBlanc; Diana J Donovan; Swan N Thung; Manel Solé; Victoria Tovar; Clara Alsinet; Alex H Ramos; Jordi Barretina; Sasan Roayaie; Myron Schwartz; Samuel Waxman; Jordi Bruix; Vincenzo Mazzaferro; Azra H Ligon; Vesna Najfeld; Scott L Friedman; William R Sellers; Matthew Meyerson; Josep M Llovet
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

2.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.

Authors:  Sandrine Boyault; David S Rickman; Aurélien de Reyniès; Charles Balabaud; Sandra Rebouissou; Emmanuelle Jeannot; Aurélie Hérault; Jean Saric; Jacques Belghiti; Dominique Franco; Paulette Bioulac-Sage; Pierre Laurent-Puig; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

Review 3.  Hepatocellular carcinoma: insight from animal models.

Authors:  Yan Li; Zhao-You Tang; Jin-Xuan Hou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

4.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

Authors:  Claire Dunn; Dimitra Peppa; Pooja Khanna; Gaia Nebbia; Meleri Jones; Nathan Brendish; R Monica Lascar; David Brown; Richard J Gilson; Richard J Tedder; Geoffrey M Dusheiko; Michael Jacobs; Paul Klenerman; Mala K Maini
Journal:  Gastroenterology       Date:  2009-07-07       Impact factor: 22.682

5.  Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.

Authors:  Marianna Hösel; Maria Quasdorff; Katja Wiegmann; Dennis Webb; Uta Zedler; Mathias Broxtermann; Raindy Tedjokusumo; Knud Esser; Silke Arzberger; Carsten J Kirschning; Anja Langenkamp; Christine Falk; Hildegard Büning; Stefan Rose-John; Ulrike Protzer
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 6.  The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses.

Authors:  Alison Crawford; E John Wherry
Journal:  Curr Opin Immunol       Date:  2009-03-04       Impact factor: 7.486

7.  The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression.

Authors:  Jung-Hwan Kim; Jiann-Kae Luo; Dong-Er Zhang
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

8.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

Authors:  Damien Chaussabel; Charles Quinn; Jing Shen; Pinakeen Patel; Casey Glaser; Nicole Baldwin; Dorothee Stichweh; Derek Blankenship; Lei Li; Indira Munagala; Lynda Bennett; Florence Allantaz; Asuncion Mejias; Monica Ardura; Ellen Kaizer; Laurence Monnet; Windy Allman; Henry Randall; Diane Johnson; Aimee Lanier; Marilynn Punaro; Knut M Wittkowski; Perrin White; Joseph Fay; Goran Klintmalm; Octavio Ramilo; A Karolina Palucka; Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

Review 9.  SOCS proteins, cytokine signalling and immune regulation.

Authors:  Akihiko Yoshimura; Tetsuji Naka; Masato Kubo
Journal:  Nat Rev Immunol       Date:  2007-05-18       Impact factor: 53.106

10.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.

Authors:  Yujin Hoshida; Sebastian M B Nijman; Masahiro Kobayashi; Jennifer A Chan; Jean-Philippe Brunet; Derek Y Chiang; Augusto Villanueva; Philippa Newell; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Stacey Gabriel; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701

View more
  47 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Marie-Annick Buendia; Christine Neuveut
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

2.  Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages.

Authors:  Xiaoming Cheng; Yuchen Xia; Elisavet Serti; Peter Daniel Block; Michelle Chung; Kazuaki Chayama; Barbara Rehermann; T Jake Liang
Journal:  Hepatology       Date:  2017-12       Impact factor: 17.425

3.  Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Donavan T Cheng; Palanikumar Ravindran; Hans Bitter; Lore Gruenbaum; Paul J Cote; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

Review 4.  The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Authors:  Michael Roggendorf; Anna D Kosinska; Jia Liu; Mengji Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-28       Impact factor: 6.915

5.  Measurement of Antiviral Effect and Innate Immune Response During Treatment of Primary Woodchuck Hepatocytes.

Authors:  Marta G Murreddu; Manasa Suresh; Severin O Gudima; Stephan Menne
Journal:  Methods Mol Biol       Date:  2017

Review 6.  Immune Response in Hepatitis B Virus Infection.

Authors:  Anthony Tan; Sarene Koh; Antonio Bertoletti
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 7.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

8.  Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.

Authors:  Stephan Menne; Daniel B Tumas; Katherine H Liu; Linta Thampi; Dalal AlDeghaither; Betty H Baldwin; Christine A Bellezza; Paul J Cote; Jim Zheng; Randall Halcomb; Abigail Fosdick; Simon P Fletcher; Stephane Daffis; Li Li; Peng Yue; Grushenka H I Wolfgang; Bud C Tennant
Journal:  J Hepatol       Date:  2015-01-02       Impact factor: 25.083

9.  Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.

Authors:  Junbo Chen; Wei Xu; Yanni Chen; Xueping Xie; Yecheng Zhang; Chunqiang Ma; Qingyu Yang; Yang Han; Chengliang Zhu; Ying Xiong; Kailang Wu; Fang Liu; Yingle Liu; Jianguo Wu
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

10.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Authors:  Xiuji Cui; Daniel N Clark; Kuancheng Liu; Xiao-Dong Xu; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.